Literature DB >> 3324457

In vitro adhesion of K88ab-, K88ac- and K88ad-positive Escherichia coli to intestinal villi, to buccal cells and to erythrocytes of weaned piglets.

E Cox1, A Houvenaghel.   

Abstract

The phenotype of 21 weaned piglets, concerning adhesion of Escherichia coli possessing K88ab, K88ac or K88ad fimbriae to pig cells, was determined in an in vitro assay. Comparison was made with adhesion of these three K88 variant strains to buccal mucosal epithelial cells and to erythrocytes (haemagglutination) in the same piglets. Whereas adhesion of the three K88 variant strains to intestinal villi was piglet specific, buccal cell adhesion (BCA) and haemagglutination (HA) were not. The K88ab strain was weakly adhesive or non-adhesive in the BCA and negative in the HA test. K88ac strains consistently gave negative and K88ad consistently gave positive results in both assays. After washing the bacteria with phosphate-buffered saline, the K88ab strain revealed a positive HA test. Neither the BCA, nor HA test can be used to determine the pig intestinal adhesive phenotype.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3324457     DOI: 10.1016/0378-1135(87)90074-5

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  3 in total

1.  High prevalence of F4+ and F18+ Escherichia coli in Cuban piggeries as determined by serological survey.

Authors:  Pedro Yoelvys de la Fé Rodríguez; Annelies Coddens; Emanuele Del Fava; José Cortiñas Abrahantes; Ziv Shkedy; Luis O Maroto Martin; Eduardo Cruz Muñoz; Luc Duchateau; Eric Cox; Bruno Maria Goddeeris
Journal:  Trop Anim Health Prod       Date:  2011-01-14       Impact factor: 1.559

2.  Oral administration of protease inhibits enterotoxigenic Escherichia coli receptor activity in piglet small intestine.

Authors:  T L Mynott; R K Luke; D S Chandler
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

Review 3.  Swine and cattle enterotoxigenic Escherichia coli-mediated diarrhea. Development of therapies based on inhibition of bacteria-host interactions.

Authors:  M Mouricout
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.